Search Results

You are looking at 81 - 90 of 251 items for :

  • "Acute myeloid leukemia" x
  • Refine by Access: All x
Clear All
Full access

CLO24-084: Myeloid Sarcoma in a Patient With Marfan Syndrome

Nitya Batra, Atulya Aman Khosla, Shyam Poudel, and Daniel Ezekwudo

myeloid leukemia (AML), however, it can occur solitarily or coexist with myelodisplastic syndrome (MDS) and other myeloproliferative neoplasms. Most common isolated sites are skin, bone, soft tissues and lymph nodes. We present a rare gastrointestinal

Full access

EPR22-104: A Comparison of the Burden of Leukemia Amongst Various Regions of the World, 1990-2019

Alaaeldin Ahmed, Chinmay Jani, Padmanabh Bhatt, Harpreet Singh, Ruchi Jani, Joseph Shalhoub, Dominic Marshall, Prudence Lam, and Justin Salciccioli

Background : Acute Myeloid Leukemia (AML) is the most common acute leukemia in adults accounting for about 80% of adult leukemia cases. In contrast, it accounts for less than 10% of children less than ten years of age. In the last two decades

Full access

QIM23-131: A Retrospective Review of Myelodysplastic Syndrome Management (MDS) at Watson Clinic LLP: From Diagnosis to Primary Course of Treatment

Shane Burke, Galina Vugman, Noreen McGowan, and Michelle Sharrett

Comprehensive Cancer Network (NCCN) Guidelines recommend treatment patterns based on risk of progression into Acute Myeloid Leukemia (AML). Adherence to these guidelines improves survival rates in patients with MDS. An MDS work-up should include an extensive

Full access

HSR24-159: Relationship Between Durable Transfusion Independence (TI) and Survival Outcomes in Patients (Pts) With Lower-Risk Myelodysplastic Syndrome (LR-MDS): An Analysis From US Health Insurance Claims Data

Rami S. Komrokji, Nishan Sengupta, Dylan Supina, Shyamala Navada, Ravi Potluri, Rohit Tyagi, Timothy Werwath, Zhouer Xie, Eric Padron, and David Sallman

.1, D46.9, D46.A, and D46.B) from Oct 2015 to Mar 2023. No diagnosis of MDS/acute myeloid leukemia (AML) or use of higher-risk MDS or AML medication before their respective index diagnosis dates were allowed. Lines of treatment were determined by the

Full access

Developmental Therapeutics for Myelodysplastic Syndromes

Aung Naing, Lubomir Sokol, and Alan F. List

. 22. Foran J Paquette R Copper M . A phase I study of repeated oral dosing with SU11248 for the treatment of patients with acute myeloid leukemia who have failed or are not eligible for conventional chemotherapy [abstract] . Blood 2002 ; 100

Full access

Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress

Constantine S. Mitsiades and Kenneth C. Anderson

-sensitive ovarian tumors . Nat Med 2003 ; 9 : 568 - 574 . 54. Melki JR Vincent PC Clark SJ . Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia . Cancer Res 1999 ; 59 : 3730 - 3740 . 55. Hegi ME Liu L Herman JG

Full access

Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database

Guru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Sameem Abedin, and Ehab Atallah

Background Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML) that is characterized by chromosomal translocation t(15;17) with fusion of PML-RARA genes and cell-cycle arrest at the promyelocyte stage. 1 APL

Full access

Treatment Disparities Faced by Undocumented Workers From Low- and Middle-Income Countries in the United States With Hematologic Malignancies

Sara E. Nunnery, Andrew E. Fintel, W. Clay Jackson, Jason C. Chandler, Michael O. Ugwueke, and Mike G. Martin

urgent leukapheresis, a bone marrow biopsy was performed and a diagnosis of acute myeloid leukemia (AML) was made. He was started on induction chemotherapy with cytarabine, idarubicin, and cladribine (7+3+5). 4 The final bone marrow biopsy revealed high

Full access

Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy

Sophia Koo and Lindsey R. Baden

lymphoproliferative disorders . Blood 2002 ; 100 : 3121 – 3127 . 51. Ho AY Pagliuca A Kenyon M . Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia

Full access

The NCCN 2019 Annual Congress: Hematologic Malignancies

Robert W. Carlson

neoplasms. Also in the congress, blood cancer experts described updates in treatment strategies for Hodgkin lymphoma, advances in first-line acute myeloid leukemia management, and progress in personalized therapeutic approaches in myelodysplastic syndromes